PLK1 and neoplasm: Genetic and pharmacological inhibition of PLK1 showed a strong combinatorial effect with oxaliplatin to block tumorsphere formation, indicating the critical role of PLK1 in tumor‐initiation capability (Figure 3F,G; Figure S3C, Supporting Information).